fashion -WSS

fashion

author：explore 2025-09-27 13:09:59 - browse：7

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Colorectal cancer study finds potential in overlooked immune cell

WSS

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

The future of health care in the House

Colorectal cancer study finds potential in overlooked immune cell

Study: Spinal cord stimulation helps patients with paralysis walk again

VC firm General Catalyst wants to buy a health system

Liquid biopsy for lung cancer is launched by Delfi

hotspot

fashion

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Senate panel eyes new effort on drug shortages

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Sports medicine is finally prioritizing gender equality

CDC says it’s too soon to assess risk posed by Covid subvariant

DIEP, the 'gold standard' of breast reconstruction, is under threat

PBMs are inflating the cost of generic drugs. They must be reined in

23andMe had bad news about my health. I wish a person had delivered it

How the drug

explore

DeSantis wants to import drugs. Biden’s FDA blasted his plan

National associations that represent hospice owe an apology

Chemotherapy drug shortage eases slightly but still widespread

Hospital at home shows how to bring innovation to health care

FDA rejects Alnylam's heart disease treatment over insufficient data

Senate panel eyes new effort on drug shortages

leisure time

focus

knowledge

explore